Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.3B | 1.3B | 1.3B | 1.3B |
Cost of revenue | 527M | 544M | 531M | 514M |
Gross profit | 805M | 801M | 783M | 774M |
Operating expense | ||||
Research & development | 64M | 69M | 63M | 61M |
Selling general and admin | 419M | 424M | 412M | 414M |
Other operating expenses | — | — | — | — |
Operating income | 322M | 308M | 308M | 299M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 27M | 28M | 27M | 30M |
Other income expense | -6M | 0 | 5M | 1M |
Pretax income | 289M | 280M | 286M | 270M |
Tax provision | 64M | 53M | 67M | 67M |
Net income | 225M | 227M | 219M | 203M |
Basic EPS | — | 0.9 | 0.9 | 0.8 |
Diluted EPS | — | 0.9 | 0.9 | 0.8 |
Basic average shares | — | 247.6M | 247.4M | 247.2M |
Diluted average shares | — | 250.3M | 250M | 249.3M |
EBITDA | 335M | 328M | 330M | 320M |
Net income from continuing op. | 225M | 227M | 219M | 203M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |